EASE-SOT Pilot Study

Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Apr 29, 2024

Keywords

ClinConnect Summary

The EASE-SOT Pilot Study is a clinical trial designed to help organ transplant recipients manage physical and emotional symptoms that can affect their quality of life after transplantation. Many patients experience issues like anxiety, fatigue, and sleep problems, which often go unreported and untreated. The EASE intervention aims to support these patients by providing counseling sessions with mental health professionals and regular assessments of their symptoms using questionnaires. This approach is intended to help identify and address any concerns related to their physical and emotional well-being.

To participate in this study, individuals must be on the transplant waitlist or have recently received a kidney, heart, liver, lung, or pancreas transplant. Eligible participants will be those who can provide informed consent and are not dealing with severe mental health issues or cognitive impairments. Throughout the trial, participants can expect to receive support and guidance from specialists to help them cope with their experiences and improve their overall health after transplantation. Please note that the study is not yet recruiting participants.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants consented pre-transplant: Potential transplant recipients who are listed on the waitlist and are identified by pre-transplant staff, recipients who have a living donor arranged (pertaining to kidney and liver recipients), participants currently completely pre-transplant prehabilitation (pertaining to lung and heart recipients), or those who are on the top of their respective organ transplant waitlists.
• • Participants consented post-transplant: Incident kidney, kidney-pancreas, liver, lung, or heart transplant recipients identified during index transplant hospital admission at the inpatient transplant unit of the Ajmera Transplant Centre at Toronto General Hospital
• Exclusion Criteria:
• • Patients in ICU.
• • Patients who are clinically unstable, have delirium or other severe mental health concern requiring psychiatric treatment - assessed by clinical team.
• • Non-English speaking patients.
• • Severe cognitive impairment as assessed by the recruitment and/or research team. This will be determined through communication with the organ transplant teams and by checking the patient's medical charts. If no cognitive impairment is indicated by the patients organ transplant team or is documented in their medical chart, the patient will be assessed to have no cognitive impairment.
• • Unwilling or unable to provide informed consent.